Position in RLAY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$88,434,236
+$53,503,409 QoQ
Shares Held
4,726,576
+34.6% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. RLAY ranks #50 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,434,236 | 4,726,576 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $34,930,827 | 3,510,636 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,843,210 | 3,409,363 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $15,944,937 | 3,054,586 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $11,174,644 | 3,229,666 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,043,708 | 3,070,118 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,484,246 | 3,030,157 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $19,344,470 | 2,732,270 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,418,475 | 2,364,797 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $18,399,381 | 2,216,793 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $22,917,425 | 2,081,510 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16,576,009 | 1,970,988 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,628,625 | 1,881,260 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $28,897,109 | 1,754,530 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,310,167 | 1,694,121 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $34,695,310 | 1,550,975 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,897,627 | 1,426,724 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $40,479,636 | 1,352,477 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $40,077,041 | 1,305,016 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $33,587,647 | 1,065,260 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $25,901,878 | 707,895 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,877,963 | 603,933 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $18,536,757 | 446,024 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $18,611,063 | 436,982 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||